Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis

16 Jul 2024

Abstract excerpt

Non-alcoholic steatohepatitis (NASH) is a hepatocyte inflammation based on hepatocellular steatosis, yet there is no effective drug treatment. Atherosclerosis (AS) is caused by lipid deposition in the endothelium, which can lead to various cardiovascular diseases. NASH and AS share common risk factors, and NASH can also elevate the risk of AS, causing a higher morbidity and mortality rate for atherosclerotic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Liver Disease Diagnosis and Treatment
Share to Peroxisome Proliferator-Activated Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39013959
DOI: 10.1038/s41598-024-66287-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitisPMID 39013959Read ↗

Identifying disease progression biomarkers in metabolic associated steatotic liver disease (MASLD) through weighted gene co-expression network analysis and machine learningSemantic proximity Read ↗

Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosisSemantic proximity Read ↗

Bioinformatics based analysis of the underlying comorbidity mechanisms of non-alcoholic steatohepatitis and primary biliary cholangitisSemantic proximity Read ↗

Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathySemantic proximity Read ↗

Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analysesSemantic proximity Read ↗

Identification and verification of immune-related genes for diagnosing the progression of atherosclerosis and metabolic syndrome.Semantic proximity Read ↗

Bioinformatics analysis to reveal the potential comorbidity mechanism in psoriasis and nonalcoholic steatohepatitisSemantic proximity Read ↗

Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysisSemantic proximity Read ↗

Identification of ITGAX and CCR1 as potential biomarkers of atherosclerosis via Gene Set Enrichment AnalysisSemantic proximity Read ↗

IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental studySemantic proximity Read ↗

Identification of Hub Genes Associated With Non-alcoholic Steatohepatitis Using Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Bioinformatics analysis explores potential hub genes in nonalcoholic fatty liver diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.